Coya Therapeutics, Inc.
USD5.85
-0.22 (-3.62%)
CEO
Arun Swaminathan
IPO Date
2022-12-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.04
Prev. Close
$6.07
Day Low
$5.85
Day High
$6.21
52W Low
$3.71
52W High
$7.75
Market Cap
$0.11B
Volume
0.30M
| -5.9 |
| 31 Dec 2023 | FY | 8.3% | -133.1% | -22.4% | -19.4% | 0.00 | 8.15 | -9.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 145.9% | -145.8% | -1.54 | 1.88 | -3.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -134.3% | -102.1% | 0.00 | 3.99 | -6.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -13.2% | -12.6% | 0.00 | 19.57 | -10.8 |
| -4.2 |
| 30 Sept 2025 | Q3 | 99.8% | -59.4% | -7.8% | -6.6% | 0.00 | 8.73 | -11.3 |
| 30 Jun 2025 | Q2 | 95.8% | -3725.2% | -21.5% | -18.2% | 0.00 | 7.43 | -3.9 |
| 31 Mar 2025 | Q1 | -1921.9% | -2833.4% | -21.9% | -19.0% | 0.00 | 8.84 | -3.7 |
| 31 Dec 2024 | Q4 | -99154.1% | -149373.8% | -7.4% | -6.6% | 0.00 | 11.59 | -8.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -12.6% | -11.3% | 0.00 | 15.31 | -6.1 |
| 30 Jun 2024 | Q2 | -33.3% | -84.4% | -8.2% | -7.2% | 0.00 | 10.43 | -7.9 |
| 31 Mar 2024 | Q1 | -2374.1% | -3983.0% | -15.6% | -13.5% | 0.00 | 8.64 | -7.0 |
| 31 Dec 2023 | Q4 | 73.2% | 21.1% | 3.6% | 3.1% | 0.00 | 8.15 | 14.9 |